Yu-Waye Chu - Nov 19, 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role: Senior VP Clinical Development
Signature: /s/ Cindy Tahl, Attorney-in-Fact
Stock symbol: FATE
Transactions as of: Nov 19, 2021
Transactions value $: $0
Form type: 4
Date filed: 11/22/2021, 04:38 PM
Next filing: Dec 13, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FATE	Common Stock	Award	$0	+61K	+94.07%	$0.00	126K	Nov 19, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were granted pursuant to a performance-based restricted stock unit award. The units will vest in three approximately equal installments conditioned upon the achievement, on or before December 31, 2026, of up to three specified late-stage clinical and regulatory milestones of the issuer, so long as the reporting person continues to serve as an employee of the issuer through each milestone achievement.

Content

These shares were granted pursuant to a performance-based restricted stock unit award. The units will vest in three approximately equal installments conditioned upon the achievement, on or before December 31, 2026, of up to three specified late-stage clinical and regulatory milestones of the issuer, so long as the reporting person continues to serve as an employee of the issuer through each milestone achievement.